Patient Gateway

RSS Feed

Management of Adverse Events Associated with MET TKIs in Patients with Advanced NSCLC: A Podcast Discussion

周建娅教授：长生存领航，ROS1融合晚期NSCLC开启精准治疗新篇章！_腾讯新闻

Case Report: Can this 90-year-old patient with cT4N3M0 NSCLC have concurrent chemoradiation for cure? Learning from a representive case

Gilberto Lopes: Where Does Sevabertinib Fit in HER2-Mutant NSCLC?

Sevabertinib Approved for First-Line Mutated NSCLC

Targeted Therapy in Advanced NSCLC: From Driver Matching to Adaptive Precision Oncology

NSCLC: FDA Grants Accelerated Approval to Sevabertinib for Locally Advanced or Metastatic Nonsquamous Disease

Hyrnuo Expands to 1L HER2 TKD NSCLC: SOHO-01 Treatment-Naïve ORR 75%

An exploratory case series of sequential stereotactic body radiotherapy and tislelizumab after platinum-doublet chemotherapy in stage IIIB/C–IV non-squamous NSCLC